Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05853601 · ClinicalTrials.gov registry record · Phase 1
Theophylline Prophylaxis During Hypothermia to Limit Neonatal Nephron Damage
A Phase 1 study of Acute Kidney Injury and HIE, sponsored by Medical College of Wisconsin.
- Recruiting
- Registry status
- Phase 1
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT05853601 is a Phase 1 study of Acute Kidney Injury and HIE that is actively recruiting participants, run by Medical College of Wisconsin. The registered enrollment target is 30 participants, below the 2,331-participant average among 74 other Acute Kidney Injury trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05853601, a Phase 1 study of Acute Kidney Injury and HIE, is actively recruiting participants, sponsored by Medical College of Wisconsin.
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
Acute kidney injury is a significant complication for infants who experience hypoxic ischemic encephalopathy, being associated with increased rates of death and prolonged hospitalization. This pilot study of theophylline administration soon after birth for the prevention of kidney injury will lay the foundation for the conduct of a larger clinical trial that seeks to identify a theophylline as a novel therapy to prevent kidney injury in thousands of at-risk infants.
Conditions Studied
Interventions
- DRUG Single Dose Theophylline
- DRUG Repeat Dose Theophylline
Study Locations (1)
Oklahoma
- University of Oklahoma Health Sciences Center - Oklahoma City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2023-10-17 |
| Est. Completion | 2027-04-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05853601
The ClinicalTrials.gov registry entry for NCT05853601 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,331-participant average among 74 other Acute Kidney Injury trials with a reported enrollment target (99% lower). The listed sponsor is Medical College of Wisconsin, which has 447 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Acute Kidney Injury appearing as the primary indexed condition, and to 2 interventions - of which Single Dose Theophylline is the first listed.
NCT05853601 reports 1 study location spanning 1 distinct geographic area - top geographies include Oklahoma.
Frequently Asked Questions
What is clinical trial NCT05853601 about?
NCT05853601 is a clinical study titled "Theophylline Prophylaxis During Hypothermia to Limit Neonatal Nephron Damage". Acute kidney injury is a significant complication for infants who experience hypoxic ischemic encephalopathy, being associated with increased rates of death and prolonged hospitalization. This pilot study of theophylline administration soon after birth for the prevention of kidney injury will lay th...
What is the current status of trial NCT05853601?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 30 participants. The study started on 2023-10-17. Estimated completion is 2027-04-01.
What conditions does trial NCT05853601 study?
This clinical trial studies the following conditions: Acute Kidney Injury, HIE.
What interventions are being tested in trial NCT05853601?
The interventions under investigation include: Single Dose Theophylline (DRUG), Repeat Dose Theophylline (DRUG).
Who is sponsoring clinical trial NCT05853601?
This trial is sponsored by Medical College of Wisconsin, which has 447 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05853601 being conducted?
This trial has 1 study location across Oklahoma. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acute Kidney Injury
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Allogeneic HB-adMSCs vs Placebo for the Treatment of Acute Kidney Injury
RECRUITING · Phase 1
-
A Study of the PK Interaction of CXA-10 With Pravastatin and Vytorin® in Healthy Males
COMPLETED · Phase 1
-
Ibuprofen and Biomarkers of Acute Kidney Injury After Running in the Heat
COMPLETED · Phase 1
-
Pharmacokinetics of MP-3180 and Use of Noninvasive Fluorescence Detection Device in Healthy Volunteers
COMPLETED · Phase 1
-
Ultra-Low Contrast Angiography in AKI
RECRUITING · Phase 3
-
Novel Treatments in Improving Renal Outcomes in Light Chain Cast Nephropathy
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.